How Europe is grappling with extreme heat as red alerts issued in Britain, France, Spain and Italy

11 hours ago

UPS to invest $48 million in cold facilities amid GLP-1 boom

11 hours ago

SNAP restrictions could change what shoppers buy — and food giants are watching

3 days ago

U.S. opens tariff probe targeting Germany's drug pricing policies

4 days ago

What this biotech's volatile stock price tells you about the weight loss market right now

4 days ago

UniQure to seek FDA approval for Huntington's disease gene therapy in reversal

4 days ago

Biotech IPO revival faces competition from cash-rich big pharma buyers

7 days ago

Centene to offer buyouts to some employees as health insurer cuts costs

8 days ago

Drugmakers race to find a place in the next wave of obesity drugs

10 days ago

CVS Health executives on reducing healthcare's biggest pain points

10 days ago

Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'

12 days ago

How screwworm in U.S. cattle herds could re-inflate record beef prices

13 days ago

The space race is coming for pharma: Why drug development is heading to orbit

13 days ago

Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion

14 days ago

Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why

15 days ago

GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors

15 days ago

Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says

15 days ago

Weight loss drug maker sinks 23% after new safety data spooks investors

15 days ago

U.S. confirms second Texas screwworm case, Canada restricts livestock imports

17 days ago

AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success

17 days ago

Warren Buffett disciple Guy Spier's rare cancer changed how he values everything

17 days ago

An 'EpiPen' for heart attacks?: The market has yet to give this drug stock credit

18 days ago

As the World Cup kicks off, health officials are focused on more than Ebola

19 days ago

'Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid

19 days ago

Eli Lilly's top dealmaker says don't be surprised to see more M&A

19 days ago

Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug

14 days ago

Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial

21 days ago

Why Trump reversed course to fast-track psychedelic drugs for mental healthcare

23 days ago

Replimune to resubmit twice rejected drug for approval after FDA shakeup

23 days ago

Oura is launching its smallest smart ring yet, shrinking wearable design by 40%

26 days ago

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans

26 days ago

Amazon's top health exec is stepping down, will be replaced by Amwell co-founder

26 days ago